Literature DB >> 22036516

Excess risk of temporomandibular disorder associated with cigarette smoking in young adults.

Anne E Sanders1, William Maixner, Andrea G Nackley, Luda Diatchenko, Kunthel By, Vanessa E Miller, Gary D Slade.   

Abstract

UNLABELLED: Evidence suggests that the effect of cigarette smoking on chronic pain is stronger in younger than older adults. This case-control study investigated whether age modified an effect of smoking on temporomandibular disorder (TMD) in 299 females aged 18 to 60 years. It also investigated the extent to which this relationship was explained by psychological profile, inflammatory response, and allergy. Cases were defined using the Research Diagnostic Criteria for Temporomandibular Disorders based on clinical examination. Psychological profile was evaluated using standardized instruments. Inflammatory response was evaluated with 11 cytokines isolated in plasma. History of allergy conditions was self-reported. Odds ratios (ORs) for the effect of smoking were calculated using binary logistic regression. Stratified analyses and the likelihood ratio test examined effect modification by smoking. Compared with nonsmokers, ever smokers aged <30 years had higher odds of TMD (OR = 4.14, 95% CI: 1.57, 11.35) than older adults (OR = 1.23, 95% CI: .55, 2.78) (P (effect modification) = .038). Adjustment for psychological profile, cytokines, and history of allergy-like conditions attenuated the effect by 45% to statistical nonsignificance. The main finding was reproduced with secondary analyses of 2 nationally representative surveys of adults conducted in the US and Australia. PERSPECTIVE: This study showed that smoking was associated with TMD risk in females, but only in young adulthood. It replicated this finding in 2 nationally representative surveys of females in the US and Australia. Findings may alert clinicians to recognize that smoking is a concern for TMD in younger female patients.
Copyright © 2012 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036516      PMCID: PMC3249502          DOI: 10.1016/j.jpain.2011.08.003

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  66 in total

1.  cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium.

Authors:  S Haskill; G Martin; L Van Le; J Morris; A Peace; C F Bigler; G J Jaffe; C Hammerberg; S A Sporn; S Fong
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

3.  Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers.

Authors:  Andrew Rawlinson; John M Grummitt; Trevor F Walsh; C W Ian Douglas
Journal:  J Clin Periodontol       Date:  2003-01       Impact factor: 8.728

4.  Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats.

Authors:  X Wang; F C Barone; N V Aiyar; G Z Feuerstein
Journal:  Stroke       Date:  1997-01       Impact factor: 7.914

5.  Proinflammatory or regulatory cytokines released from BALF macrophages of healthy smokers.

Authors:  T Mikuniya; S Nagai; T Tsutsumi; K Morita; T Mio; N Satake; T Izumi
Journal:  Respiration       Date:  1999       Impact factor: 3.580

6.  IgE levels, atopy markers and hay fever in relation to age, sex and smoking status in a normal adult Swiss population. SAPALDIA (Swiss Study on Air Pollution and Lung Diseases in Adults) Team.

Authors:  B Wüthrich; C Schindler; T C Medici; J P Zellweger; P Leuenberger
Journal:  Int Arch Allergy Immunol       Date:  1996-12       Impact factor: 2.749

7.  Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses.

Authors:  J Menetski; S Mistry; M Lu; J S Mudgett; R M Ransohoff; J A Demartino; D E Macintyre; C Abbadie
Journal:  Neuroscience       Date:  2007-08-14       Impact factor: 3.590

8.  MCP-1 and CCR2 gene polymorphisms in Czech patients with allergic disorders.

Authors:  L Izakovicova Holla; F Mrazek; M Petrek
Journal:  Int J Immunogenet       Date:  2008-11-25       Impact factor: 1.466

9.  Cigarette smoke facilitates allergen penetration across respiratory epithelium.

Authors:  K Gangl; R Reininger; D Bernhard; R Campana; I Pree; J Reisinger; M Kneidinger; M Kundi; H Dolznig; D Thurnher; P Valent; K-W Chen; S Vrtala; S Spitzauer; R Valenta; V Niederberger
Journal:  Allergy       Date:  2008-12-16       Impact factor: 13.146

10.  Depression, anxiety, and smoking initiation: a prospective study over 3 years.

Authors:  G C Patton; J B Carlin; C Coffey; R Wolfe; M Hibbert; G Bowes
Journal:  Am J Public Health       Date:  1998-10       Impact factor: 9.308

View more
  10 in total

1.  Sleep apnea symptoms and risk of temporomandibular disorder: OPPERA cohort.

Authors:  A E Sanders; G K Essick; R Fillingim; C Knott; R Ohrbach; J D Greenspan; L Diatchenko; W Maixner; R Dubner; E Bair; V E Miller; G D Slade
Journal:  J Dent Res       Date:  2013-05-20       Impact factor: 6.116

2.  The Effect of Tobacco Smoking on Musculoskeletal Health: A Systematic Review.

Authors:  Ahmad M Al-Bashaireh; Linda G Haddad; Michael Weaver; Debra Lynch Kelly; Xing Chengguo; Saunjoo Yoon
Journal:  J Environ Public Health       Date:  2018-07-11

3.  Role of allostatic load in sociodemographic patterns of pain prevalence in the U.S. population.

Authors:  Gary D Slade; Anne E Sanders; Kunthel By
Journal:  J Pain       Date:  2012-06-05       Impact factor: 5.820

4.  Chronic HPA axis response to stress in temporomandibular disorder.

Authors:  Cynthia A Lambert; Anne Sanders; Rebecca S Wilder; Gary D Slade; Stan Van Uum; Evan Russell; Gideon Koren; William Maixner
Journal:  J Dent Hyg       Date:  2013-04

5.  Current smoking as a predictor of chronic musculoskeletal pain in young adult twins.

Authors:  Amy Lewandowski Holley; Emily F Law; See Wan Tham; Mon Myaing; Carolyn Noonan; Eric Strachan; Tonya M Palermo
Journal:  J Pain       Date:  2013-07-01       Impact factor: 5.820

6.  Chronic HPA axis response to stress in temporomandibular disorder.

Authors:  Cynthia A Lambert; Anne Sanders; Rebecca S Wilder; Gary D Slade; Stan Van Uum; Evan Russell; Gideon Koren; William Maixner
Journal:  J Dent Hyg       Date:  2014

7.  General health status and incidence of first-onset temporomandibular disorder: the OPPERA prospective cohort study.

Authors:  Anne E Sanders; Gary D Slade; Eric Bair; Roger B Fillingim; Charles Knott; Ronald Dubner; Joel D Greenspan; William Maixner; Richard Ohrbach
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

8.  Mast cell stabilizer ketotifen fumarate reverses inflammatory but not neuropathic-induced mechanical pain in mice.

Authors:  Carolina B Meloto; Pablo Ingelmo; Eduardo Vega Perez; Rebecca Pitt; Víctor Hugo González Cárdenas; Nada Mohamed; Susana G Sotocinal; Valerie Bourassa; Lucas Vasconcelos Lima; Alfredo Ribeiro-da-Silva; Jeffrey S Mogil; Luda Diatchenko
Journal:  Pain Rep       Date:  2021-06-03

9.  Effect of smoking status and nicotine dependence on pain intensity and outcome of treatment in Indian patients with temporomandibular disorders: A longitudinal cohort study.

Authors:  Preeti Agarwal Katyayan; Manish Khan Katyayan
Journal:  J Indian Prosthodont Soc       Date:  2017 Apr-Jun

10.  Efficacy of the LED Red Light Therapy in the Treatment of Temporomandibular Disorders: Double Blind Randomized Controlled Trial.

Authors:  Ahmed Fadhel Al-Quisi; Auday M Al-Anee; Hassanien A Al-Jumaily; Eman F Bahr; Dina A Finjan
Journal:  Pain Res Treat       Date:  2019-05-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.